Diprivan 10mg/ml (1%) emulsion for injection or infusion.

Ülke: Malezya

Dil: İngilizce

Kaynak: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktif bileşen:

PROPOFOL/2,6-DIISOPROPYLPHENOL

Mevcut itibaren:

Aspen Medical Products Malaysia Sdn Bhd

INN (International Adı):

PROPOFOL/2,6-DIISOPROPYLPHENOL

Paketteki üniteler:

20ml5Units mL

Tarafından üretildi:

Corden Pharma S.P.A.

Bilgilendirme broşürü

Not Applicable

Ürün özellikleri

1
ISSUED TO THE MEDICAL PROFESSION ONLY
DIPRIVAN 10MG/ML (1%) EMULSION FOR INJECTION OR INFUSION
QUALITATIVE AND QUANTITATIVE COMPOSITION
Propofol 10mg / mL
PHARMACEUTICAL FORM
Emulsion for injection or infusion.
White aqueous isotonic oil-in-water emulsion containing Propofol
10mg/mL.
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
DIPRIVAN is a short-acting intravenous anaesthetic agent suitable for
induction and
maintenance of general anaesthesia.
DIPRIVAN may also be used for sedation of ventilated adult patients
receiving intensive care.
DIPRIVAN may also be used for conscious sedation for surgical and
diagnostic procedures.
POSOLOGY AND METHOD OF ADMINISTRATION
Supplementary analgesic agents are generally required in addition to
DIPRIVAN.
DIPRIVAN has been used in association with spinal and epidural
anaesthesia and with
commonly
used
premedicants,
neuromuscular
blocking
drugs,
inhalation
agents
and
analgesic agents; no pharmacological incompatibility has been
encountered. Lower doses
of DIPRIVAN may be required where general anaesthesia is used as an
adjunct to regional
anaesthetic techniques.
A. Adults
INDUCTION OF GENERAL ANAESTHESIA
DIPRIVAN may be used to induce anaesthesia by slow bolus injection or
infusion.
In unpremedicated and premedicated patients, it is recommended that
DIPRIVAN should be
titrated (approximately 40 mg every 10 seconds in an average healthy
adult by bolus
injection or infusion) against the response of the patient until the
clinical signs show the
onset of anaesthesia. Most adult patients aged less than 55 years are
likely to require 1.5 to
For hospital use only
2
2.5 mg/kg of DIPRIVAN. The total dose required can be reduced by lower
rates of
administration (20 - 50 mg/min). Over this age, the requirement will
generally be less. In
patients
of
ASA
Grades
3
and
4,
lower
rates
of
administration
should
be
used
(approximately 20 mg every 10 seconds).
MAINTENANCE OF GENERAL ANAESTHESIA
Anaesthesia can be maintained by administering DIPRIVAN either by
continuous infusion or
by repeat bolus